Mitsubishi UFJ Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Buy |
6,091
+366
| +6% | +$17.8K | ﹤0.01% | 923 |
|
|
2025
Q1 | $195K | Buy |
5,725
+473
| +9% | +$16.1K | ﹤0.01% | 960 |
|
|
2024
Q4 | $215K | Buy |
5,252
+372
| +8% | +$15.3K | ﹤0.01% | 979 |
|
|
2024
Q3 | $229K | Sell |
4,880
-454
| -9% | -$21.3K | ﹤0.01% | 947 |
|
|
2024
Q2 | $288K | Buy |
5,334
+2,002
| +60% | +$108K | ﹤0.01% | 923 |
|
|
2024
Q1 | $227K | Sell |
3,332
-149
| -4% | -$10.2K | ﹤0.01% | 948 |
|
|
2023
Q4 | $218K | Sell |
3,481
-1,003
| -22% | -$62.7K | ﹤0.01% | 1000 |
|
|
2023
Q3 | $204K | Buy |
4,484
+76
| +2% | +$3.45K | ﹤0.01% | 1021 |
|
|
2023
Q2 | $247K | Sell |
4,408
-272
| -6% | -$15.3K | ﹤0.01% | 1016 |
|
|
2023
Q1 | $212K | Buy |
4,680
+327
| +8% | +$14.8K | ﹤0.01% | 1021 |
|
|
2022
Q4 | $178K | Sell |
4,353
-111
| -2% | -$4.55K | ﹤0.01% | 1035 |
|
|
2022
Q3 | $292K | Buy |
4,464
+88
| +2% | +$5.76K | ﹤0.01% | 982 |
|
|
2022
Q2 | $266K | Buy |
4,376
+609
| +16% | +$37K | ﹤0.01% | 1012 |
|
|
2022
Q1 | $236K | Buy |
3,767
+300
| +9% | +$18.8K | ﹤0.01% | 1032 |
|
|
2021
Q4 | $275K | Buy |
3,467
+668
| +24% | +$53K | ﹤0.01% | 1028 |
|
|
2021
Q3 | $313K | Hold |
2,799
| – | – | ﹤0.01% | 1008 |
|
|
2021
Q2 | $453K | Sell |
2,799
-495
| -15% | -$80.1K | ﹤0.01% | 968 |
|
|
2021
Q1 | $401K | Buy |
3,294
+1,038
| +46% | +$126K | ﹤0.01% | 917 |
|
|
2020
Q4 | $345K | Sell |
2,256
-729
| -24% | -$111K | ﹤0.01% | 874 |
|
|
2020
Q3 | $250K | Sell |
2,985
-14
| -0.5% | -$1.17K | ﹤0.01% | 871 |
|
|
2020
Q2 | $220K | Buy |
2,999
+389
| +15% | +$28.5K | ﹤0.01% | 877 |
|
|
2020
Q1 | $111K | Buy |
2,610
+597
| +30% | +$25.4K | ﹤0.01% | 919 |
|
|
2019
Q4 | $120K | Sell |
2,013
-1,642
| -45% | -$97.9K | ﹤0.01% | 939 |
|
|
2019
Q3 | $150K | Buy |
3,655
+595
| +19% | +$24.4K | ﹤0.01% | 860 |
|
|
2019
Q2 | $144K | Sell |
3,060
-1,160
| -27% | -$54.6K | ﹤0.01% | 872 |
|
|
2019
Q1 | $151K | Buy |
4,220
+233
| +6% | +$8.34K | ﹤0.01% | 831 |
|
|
2018
Q4 | $112K | Buy |
3,987
+1,765
| +79% | +$49.6K | ﹤0.01% | 832 |
|
|
2018
Q3 | $99K | Buy |
+2,222
| New | +$99K | ﹤0.01% | 857 |
|